newsfilter
← Latest News
GlobeNewswire·

Milestone Pharmaceuticals to Present at Upcoming Investor Conferences

  • Milestone Pharmaceuticals Inc. (NASDAQ: MIST) announced management will present at three upcoming investor conferences in September 2026.
  • The Wells Fargo 21st Annual Healthcare Conference features a fireside chat & 1x1s on September 8, 2026, at 1:30 pm ET in Boston, MA.
  • Cantor Global Healthcare Conference in New York, NY, includes 1x1s on September 10, 2026.
  • The H.C. Wainwright 28th Annual Global Investment Conference offers a fireside chat & 1x1s on September 15, 2026, at 10:30 am ET in New York, NY.
  • Webcasts for these events will be available for approximately 90 days on the company website www.milestonepharma.com.
  • Milestone's lead product is CARDAMYST (etripamil) nasal spray, an FDA-approved calcium channel blocker for converting acute PSVT episodes to sinus rhythm in adults.
  • Etripamil is currently in Phase 3 development for controlling symptomatic episodic attacks associated with AFib-RVR.